Health
ACE2 agonist C21 relieves respiratory difficulty in COVID-19 – News-Medical.Net
A new study describes a pilot study on the efficacy of a molecule called C21, which enhances the activity of the angiotensin-converting enzyme 2 (ACE2), the host…
The advent of the coronavirus disease 2019 (COVID-19) pandemic, caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), has led to over 2.2 million deaths over a period of just over a year. The lack of effective drugs to combat the virus has led to intensive research to identify preventive and therapeutic antivirals.
A new preprint on the medRxiv* server describes a pilot study on the efficacy of a molecule called C21, which enhances the activity of the angiotensin-converting…
-
Noosa News23 hours agoJane Bunn weather: Cyclone Errol forms as effects of Alfred still felt across Queensland
-
Noosa News21 hours agoThis 42-Kilometre Walking Trail on the NSW North Coast Weaves Through Ancient Rainforest, Volcanic Mountains and Spectacular Waterfalls
-
General23 hours agoNo ‘band-aid solution’: sweating coal risky business
-
General23 hours agoParents of Heidi, 3, remember ‘beautiful’ daughter killed in Ocean Grove crash